Skip to main content

Advertisement

Log in

Tryptophan degradation in autoimmune diseases

  • Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract.

Recent evidence points to tryptophan (Trp) degradation as a potent immunosuppressive mechanism involved in the maintenance of immunological tolerance. Both Trp depletion and downstream Trp catabolites (TCs) appear to synergistically confer protection against excessive inflammation. In this review, we give an overview of the immunosuppressive properties of Trp degradation with special focus on TCs. Constitutive and inducible Trp degradation in different cell types and tissues of human and murine origin is summarized. We address the influence of Trp degradation on different aspects of autoimmune disorders such as multiple sclerosis. Possible therapeutic approaches for autoimmune disorders targeting Trp degradation are presented, and key issues relevant for the development of such therapeutic strategies are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Platten.

Additional information

Received 21 March 2007; received after revision 2 May 2007; accepted 1 June 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Opitz, C.A., Wick, W., Steinman, L. et al. Tryptophan degradation in autoimmune diseases. Cell. Mol. Life Sci. 64, 2542 (2007). https://doi.org/10.1007/s00018-007-7140-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s00018-007-7140-9

Keywords.

Navigation